Header cover image

Biotech Breakthroughs

Results

104

0 new

Companys with strong funding and high growth potential

104 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry

0LKB

Vanda Pharmaceuticals		US$4.936.4%9.9%US$282.7mUS$8.20PS1.6xE79.7%n/aPharmaceuticals & Biotech

BGNE

BeiGene		US$212.537.0%15.4%US$22.0bUS$274.14PS7.3xE64.1%n/aPharmaceuticals & Biotech

VRTX

Vertex Pharmaceuticals		US$463.15-3.1%31.4%US$119.2bUS$509.82PS11.6xE46.4%n/aPharmaceuticals & Biotech

VCYT

Veracyte		US$33.35-1.2%45.9%US$2.6bUS$33.50PS6.4xE108.1%n/aPharmaceuticals & Biotech

VITRS

Vitrolife		SEK 220.000%n/aSEK 32.8bSEK 237.49PS9.3xE105.8%0.4%Pharmaceuticals & Biotech

AUPH

Aurinia Pharmaceuticals		US$7.200%-8.6%US$1.0bUS$9.77PS5xE54.6%n/aPharmaceuticals & Biotech

NTRA

Natera		US$123.85-2.6%173.3%US$15.5bUS$130.17PS11.3xE70.5%n/aPharmaceuticals & Biotech

TRX

Tissue Regenix Group		UK£0.55-9.8%-0.9%UK£39.2mUK£1.20PS1.7xE170.8%n/aPharmaceuticals & Biotech
Page 5 of 5
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.